Zobrazeno 1 - 10
of 453
pro vyhledávání: '"P. Perco"'
Autor:
Johannes Leierer, Madonna Salib, Michail Evgeniou, Patrick Rossignol, Ziad A. Massy, Klaus Kratochwill, Gert Mayer, Bengt Fellström, Nicolas Girerd, Faiez Zannad, Paul Perco
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e30709- (2024)
Background: Statins are widely used to reduce the risk of cardiovascular disease (CVD). Patients with end-stage renal disease (ESRD) on hemodialysis have significantly increased risk of developing CVD. Statin treatment in these patients however did n
Externí odkaz:
https://doaj.org/article/e7fb5f23519140a781e57631c7a7aa83
Autor:
Felix Keller, Joachim Beige, Justyna Siwy, Alexandre Mebazaa, Dewei An, Harald Mischak, Joost P. Schanstra, Marika Mokou, Paul Perco, Jan A. Staessen, Antonia Vlahou, Agnieszka Latosinska
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background There is evidence of pre-established vulnerability in individuals that increases the risk of their progression to severe disease or death, although the mechanisms causing this are still not fully understood. Previous research has
Externí odkaz:
https://doaj.org/article/a3cf124b0572411f8e6cda3305979cf0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Deborah Perco, Federico Loi, Luca Bignardi, Luca Sbuelz, Paolo Lacovig, Ezequiel Tosi, Silvano Lizzit, Aras Kartouzian, Ueli Heiz, Alessandro Baraldi
Publikováno v:
Communications Chemistry, Vol 6, Iss 1, Pp 1-8 (2023)
Iron oxide nanoclusters are of interest for a broad range of applications, but limited experimental information on their oxidation mechanism is available outside of the gas phase. Here, the oxidation of graphene-supported size-selected Fen clusters i
Externí odkaz:
https://doaj.org/article/412c1bf065b94699b7556f979cb68646
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Glory Ranches, Maximilian Zeidler, Roman Kessler, Martina Hoelzl, Michael W. Hess, Jonathan Vosper, Paul Perco, Herbert Schramek, Kai K. Kummer, Michaela Kress, Anne Krogsdam, Michael Rudnicki, Gert Mayer, Alexander Huettenhofer
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 28, Iss , Pp 794-813 (2022)
Exosomes have emerged as a valuable repository of novel biomarkers for human diseases such as chronic kidney disease (CKD). From a healthy control group, we performed microRNA (miRNA) profiling of urinary exosomes and compared it with a cell culture
Externí odkaz:
https://doaj.org/article/e1639b6ba0ef48189e6285e9a9680784
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Infectious Diseases, Vol 95, Iss , Pp 192-197 (2020)
Objectives: To assess the association of public interest in coronavirus infections with the actual number of infected cases for selected countries across the globe. Methods: We performed a Google TrendsTM search for “Coronavirus” and compared Rel
Externí odkaz:
https://doaj.org/article/51fbf5db600445bfb7121656baf5719d
Autor:
Sara Denicolò, Viji Nair, Johannes Leierer, Michael Rudnicki, Matthias Kretzler, Gert Mayer, Wenjun Ju, Paul Perco
Publikováno v:
Biomolecules, Vol 13, Iss 1, p 89 (2022)
Fibrinogen-like 2 (FGL2) was recently found to be associated with fibrosis in a mouse model of kidney damage and was proposed as a potential therapeutic target in chronic kidney disease (CKD). We assessed the association of renal FGL2 mRNA expression
Externí odkaz:
https://doaj.org/article/2b55ea9ed8944b0b9b09a2924badd4d2
Autor:
Maria Effenberger, Andreas Kronbichler, Erica Bettac, Felix Grabherr, Christoph Grander, Timon Erik Adolph, Gert Mayer, Heinz Zoller, Paul Perco, Herbert Tilg
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 8, p e21656 (2021)
BackgroundLiver transplantation (LT) is the only curative treatment for end-stage liver disease. Less than 10% of global transplantation needs are met worldwide, and the need for LT is still increasing. The death rates on the waiting list remain too
Externí odkaz:
https://doaj.org/article/bf6552f29cfd42d28b886c920da27d11